Literature DB >> 17935788

Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index.

Vincent Casadó1, Antoni Cortés, Francisco Ciruela, Josefa Mallol, Sergi Ferré, Carmen Lluis, Enric I Canela, Rafael Franco.   

Abstract

Almost all existing models that explain heptahelical G-protein-coupled receptor (GPCR) operation are based on the occurrence of monomeric receptor species. However, an increasing number of studies show that many G-protein-coupled heptahelical membrane receptors (HMR) are expressed in the plasma membrane as dimers. We here review the approaches for fitting ligand binding data that are based on the existence of receptor monomers and also the new ones based on the existence of receptor dimers. The reasons for equivocal interpretations of the fitting of data to receptor dimers, assuming they are monomers, are also discussed. A recently devised model for receptor dimers provides a new approach for fitting data that eventually gives more accurate and physiological relevant parameters. Fitting data using the new procedure gives not only the equilibrium dissociation constants for high- and low-affinity binding to receptor dimers but also a "cooperativity index" that reflects the molecular communication within the dimer. A comprehensive way to fit binding data from saturation isotherms and from competition assays to a dimer receptor model is reported and compared with the traditional way of fitting data. The new procedure can be applied to any receptor forming dimers; from receptor tyrosine kinases to intracellular receptors (e.g., estrogen receptor) and in general for ligand binding to proteins forming dimers.

Mesh:

Substances:

Year:  2007        PMID: 17935788     DOI: 10.1016/j.pharmthera.2007.05.010

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  32 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 2.  G-protein-coupled receptor heteromers: function and ligand pharmacology.

Authors:  R Franco; V Casadó; A Cortés; J Mallol; F Ciruela; S Ferré; C Lluis; E I Canela
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 3.  G-protein-coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitter.

Authors:  Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

4.  Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.

Authors:  Carla Ferrada; Estefanía Moreno; Vicent Casadó; Gerold Bongers; Antoni Cortés; Josefa Mallol; Enric I Canela; Rob Leurs; Sergi Ferré; Carme Lluís; Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

Review 5.  On the fitting of binding data when receptor dimerization is suspected.

Authors:  J Giraldo
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

Review 6.  An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors.

Authors:  S Ferré; C Quiroz; A S Woods; R Cunha; P Popoli; F Ciruela; C Lluis; R Franco; K Azdad; S N Schiffmann
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 7.  Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity.

Authors:  Rafael Franco
Journal:  J Neural Transm (Vienna)       Date:  2008-11-11       Impact factor: 3.575

8.  Opioid-galanin receptor heteromers mediate the dopaminergic effects of opioids.

Authors:  Ning-Sheng Cai; César Quiroz; Jordi Bonaventura; Alessandro Bonifazi; Thomas O Cole; Julia Purks; Amy S Billing; Ebonie Massey; Michael Wagner; Eric D Wish; Xavier Guitart; William Rea; Sherry Lam; Estefanía Moreno; Verònica Casadó-Anguera; Aaron D Greenblatt; Arthur E Jacobson; Kenner C Rice; Vicent Casadó; Amy H Newman; John W Winkelman; Michael Michaelides; Eric Weintraub; Nora D Volkow; Annabelle M Belcher; Sergi Ferré
Journal:  J Clin Invest       Date:  2019-03-26       Impact factor: 14.808

9.  α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Authors:  Marta Sánchez-Soto; Verònica Casadó-Anguera; Hideaki Yano; Brian Joseph Bender; Ning-Sheng Cai; Estefanía Moreno; Enric I Canela; Antoni Cortés; Jens Meiler; Vicent Casadó; Sergi Ferré
Journal:  Mol Neurobiol       Date:  2018-03-18       Impact factor: 5.590

10.  Cooperative Heteroligand Interaction with G-Quadruplexes Shows Evidence of Allosteric Binding.

Authors:  Shankar Pandey; Yuanyuan Li; Montwaun D Young; Shankar Mandal; Laichun Lu; Jacob T Shelley; Hanbin Mao
Journal:  Biochemistry       Date:  2020-09-03       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.